Overview
A small fragment of growth hormone (the tail end, residues 176–191) that keeps GH’s fat-burning signal but not its blood-sugar or IGF- 1 effects.
So it nudges fat metabolism without the insulin-resistance or tumor-growth concerns of full GH.
What It Does
AOD-9604 is the C-terminal GH fragment (176–191).
It stimulates lipolysis and inhibits lipogenesis via beta-3 adrenergic signaling without raising IGF-1 or affecting glucose, the key distinction from GH- axis peptides.
Mild, additive fat-loss tool rather than a standalone heavyweight.
Reconstitution
| Vial Size | BAC Water / Solvent | Concentration |
|---|---|---|
| 2 mg | + 0.4 mL | 5 mg/mL |
| 5 mg | + 1 mL | 5 mg/mL |
| 10 mg | + 2 mL | 5 mg/mL |
Reconstitution Calculator
Enter the vial amount and diluent volume to calculate concentration. If you already have a target amount, you can also convert it to liquid volume and syringe markings. This tool does not recommend a target amount.
Enter a target amount you already have and select the syringe capacity.
Mathematical reference only. The calculator does not determine an appropriate target amount. Syringe capacity only changes the maximum volume that fits.
Protocol
| Phase | Frequency | Amount | Notes |
|---|---|---|---|
| Weeks 1–8 | Daily (5 on / 2 off) | 300 mcg | AM, fasted, into abdominal fat. 300–500 mcg range; 300 is standard. |
| Off | 4–8 weeks | – | Weekly 2-day break during the cycle helps avoid receptor desensitization. |
8–12 weeks on (5 days on / 2 off each week) / 4–8 weeks off.
first thing AM on an empty stomach, fasted state favors fat oxidation. Note: does not raise IGF-1 or glucose, so it lacks the GH-class metabolic warnings.
Unisex (a GH fragment for fat loss without GH’s growth signaling), same protocol for men and women, no cycle effect. Avoid in pregnancy.
Handling & Stacking
- Subtle, gradual fat-loss support over 8–12 weeks; best as an adjunct to diet/training or stacked with a GLP-1 or GH peptide, not a standalone fix.
- Supply math 2mg → 6 vials | 5mg → 3 vials | 10mg → 2 vials (8-wk @ 300 mcg, 5/wk)
